Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

Paclitaxel and Carboplatin in Treating Patients With Locally Advanced or Metastatic Renal Cell Cancer

ClinicalTrials.gov ID: NCT00077129

Public ClinicalTrials.gov record NCT00077129. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 21, 2026, 7:02 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Phase II Trial Of Paclitaxel Plus Carboplatin In Patients With Metastatic Or Locally Advanced Collecting Duct Renal Cell Cancer

Study identification

NCT ID
NCT00077129
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Eastern Cooperative Oncology Group
Network
Enrollment
22 participants

Conditions and interventions

Conditions

Interventions

  • carboplatin Drug
  • paclitaxel Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 120 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 31, 2006
Primary completion
Jul 31, 2006
Completion
Not listed
Last update posted
Jun 17, 2023

Started 2006

United States locations

U.S. sites
35
U.S. states
12
U.S. cities
20
Facility City State ZIP Site status
Baptist Cancer Institute - Jacksonville Jacksonville Florida 32207
Rush-Copley Cancer Care Center Aurora Illinois 60507
Robert H. Lurie Comprehensive Cancer Center at Northwestern University Chicago Illinois 60611-3013
Hematology and Oncology Associates Chicago Illinois 60611
Veterans Affairs Medical Center - Lakeside Chicago Chicago Illinois 60611
Mercy Hospital and Medical Center Chicago Illinois 60616
Swedish Covenant Hospital Chicago Illinois 60625
Midwest Center for Hematology/Oncology Joliet Illinois 60432
Joliet Oncology-Hematology Associates, Limited - West Joliet Illinois 60435
North Shore Oncology and Hematology Associates, Limited - Libertyville Libertyville Illinois 60048
Northwest Medical Specialist, PC Niles Illinois 60714
Swedish-American Regional Cancer Center Rockford Illinois 61104-2315
Hematology Oncology Associates - Skokie Skokie Illinois 60076
Hematology/Oncology of the North Shore at Gross Point Medical Center Skokie Illinois 60076
Midwest Cancer Research Group, Incorporated Skokie Illinois 60077
Carle Cancer Center at Carle Foundation Hospital Urbana Illinois 61801
CCOP - Carle Cancer Center Urbana Illinois 61801
Saint Anthony Memorial Health Centers Michigan City Indiana 46360
McFarland Clinic, P. C. Ames Iowa 50010
St. Luke's Hospital Cedar Rapids Iowa 52402
Cedar Rapids Oncology Associates Cedar Rapids Iowa 52403
Mercy Regional Cancer Center at Mercy Medical Center Cedar Rapids Iowa 52403
Borgess Medical Center Kalamazoo Michigan 49001
West Michigan Cancer Center Kalamazoo Michigan 49007-3731
Bronson Methodist Hospital Kalamazoo Michigan 49007
MeritCare Clinic - Bemidji Bemidji Minnesota 56601
Our Lady of Mercy Medical Center Comprehensive Cancer Center The Bronx New York 10466
CCOP - MeritCare Hospital Fargo North Dakota 58122
MeritCare Medical Group Fargo North Dakota 58122
St. Rita's Medical Center Lima Ohio 45801
St. Luke's Hospital Cancer Center Bethlehem Pennsylvania 18015
Avera Cancer Institute Sioux Falls South Dakota 57105
Medical X-Ray Center, PC Sioux Falls South Dakota 57105
Sioux Valley Hospital and University of South Dakota Medical Center Sioux Falls South Dakota 57117-5039
Gundersen Lutheran Cancer Center at Gundersen Lutheran Medical Center La Crosse Wisconsin 54601

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00077129, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 17, 2023 · Synced Jul 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00077129 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →